Internal Neuromodulation Market

Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.

Internal Neuromodulation Market contains market size and forecasts of Internal Neuromodulation in global, including the following market information:

• Global Internal Neuromodulation Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Internal Neuromodulation Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Internal Neuromodulation companies in 2021 (%)

The global Internal Neuromodulation market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Spinal Cord Stimulator Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Internal Neuromodulation include Medtronic PLC, Abbott, Boston Scientific Corp., Cerbomed GMBH, Cyberonics, Biocontrol Medical, Depuy Synthes Companies, Enteromedics and Synapse Biomedical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Internal Neuromodulation manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Internal Neuromodulation Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Internal Neuromodulation Market Segment Percentages, by Type, 2021 (%)

• Spinal Cord Stimulator
• Deep Brain Stimulator
• Sacral Nerve Stimulator
• Vagus Nerve Stimulator
• Gastric Neuro Stimulator

Global Internal Neuromodulation Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Internal Neuromodulation Market Segment Percentages, by Application, 2021 (%)

• Parkinsons Disease
• Chronic Pain
• Others

Global Internal Neuromodulation Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Internal Neuromodulation Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Internal Neuromodulation revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Internal Neuromodulation revenues share in global market, 2021 (%)
• Key companies Internal Neuromodulation sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Internal Neuromodulation sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Medtronic PLC
• Abbott
• Boston Scientific Corp.
• Cerbomed GMBH
• Cyberonics
• Biocontrol Medical
• Depuy Synthes Companies
• Enteromedics
• Synapse Biomedical
• Uroplasty
• Greatbatch